The House Oversight and Government Reform Committee is investigating whether Wyeth illegally promoted its drug Rapamune for unapproved use, including for the prevention of organ rejection after heart, liver, pancreas and islet cell transplants. FDA approval for the product is limited to preventing organ rejection after a kidney transplant.

Related Summaries